Dong‐Jo Chang

441 total citations
31 papers, 357 citations indexed

About

Dong‐Jo Chang is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Dong‐Jo Chang has authored 31 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Organic Chemistry and 5 papers in Pharmacology. Recurrent topics in Dong‐Jo Chang's work include Synthetic Organic Chemistry Methods (5 papers), Asymmetric Synthesis and Catalysis (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Dong‐Jo Chang is often cited by papers focused on Synthetic Organic Chemistry Methods (5 papers), Asymmetric Synthesis and Catalysis (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Dong‐Jo Chang collaborates with scholars based in South Korea. Dong‐Jo Chang's co-authors include Young‐Ger Suh, Julie Kang, Nam‐Jung Kim, Jong‐Wha Jung, Sung‐Tae Yee, Seung‐Mann Paek, Hwayoung Yun, Jae‐Kyung Jung, Dae‐Duk Kim and Jeeyeon Lee and has published in prestigious journals such as Nature Communications, Chemical Communications and International Journal of Molecular Sciences.

In The Last Decade

Dong‐Jo Chang

30 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dong‐Jo Chang South Korea 14 190 141 46 42 34 31 357
Dušan Berkeš Slovakia 17 327 1.7× 384 2.7× 35 0.8× 41 1.0× 27 0.8× 56 684
A. Yu. Misharin Russia 11 119 0.6× 211 1.5× 21 0.5× 49 1.2× 43 1.3× 57 439
Michal Jurášek Czechia 15 75 0.4× 219 1.6× 28 0.6× 58 1.4× 63 1.9× 39 453
Haigang Song China 11 119 0.6× 202 1.4× 74 1.6× 53 1.3× 17 0.5× 30 370
Ashutosh Raghuvanshi India 9 125 0.7× 162 1.1× 58 1.3× 58 1.4× 11 0.3× 14 368
Xiaobo Zhou China 14 158 0.8× 101 0.7× 37 0.8× 39 0.9× 9 0.3× 22 350
Qianhe Xu China 11 67 0.4× 138 1.0× 34 0.7× 32 0.8× 38 1.1× 21 262
Jovana J. Ajduković Serbia 13 116 0.6× 142 1.0× 31 0.7× 10 0.2× 39 1.1× 34 391
Finith E. Jernigan United States 10 125 0.7× 184 1.3× 24 0.5× 34 0.8× 15 0.4× 12 350
Michael Waibel France 9 251 1.3× 69 0.5× 20 0.4× 46 1.1× 24 0.7× 12 387

Countries citing papers authored by Dong‐Jo Chang

Since Specialization
Citations

This map shows the geographic impact of Dong‐Jo Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong‐Jo Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong‐Jo Chang more than expected).

Fields of papers citing papers by Dong‐Jo Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong‐Jo Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong‐Jo Chang. The network helps show where Dong‐Jo Chang may publish in the future.

Co-authorship network of co-authors of Dong‐Jo Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Dong‐Jo Chang. A scholar is included among the top collaborators of Dong‐Jo Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong‐Jo Chang. Dong‐Jo Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramos, S., Ji‐Yeon Han, Ho Seok Chung, et al.. (2025). Reading the immune clock: a machine learning model predicts mouse immune age from cellular patterns. Nature Communications. 17(1). 640–640.
2.
Han, Ji‐Yeon, et al.. (2023). Visualization of Metastatic Lung Cancer with TiNIR. Tomography. 9(4). 1187–1195. 3 indexed citations
3.
4.
Kim, Jong-Jin, et al.. (2022). Anti‐Inflammatory Effects of Phlebia sp. Extract in Lipopolysaccharide‐Stimulated RAW 264.7 Macrophages. BioMed Research International. 2022(1). 2717196–2717196. 3 indexed citations
5.
Kang, Julie, et al.. (2021). Bisoprolol-based 18F-PET tracer: Synthesis and preliminary in vivo validation of β1-blocker selectivity for β1-adrenergic receptors in the heart. Bioorganic & Medicinal Chemistry Letters. 36. 127789–127789. 2 indexed citations
6.
Kang, Julie, et al.. (2021). A Fluorogenic Assay: Analysis of Chemical Modification of Lysine and Arginine to Control Proteolytic Activity of Trypsin. Molecules. 26(7). 1975–1975. 4 indexed citations
7.
Kang, Julie, Jun Young Lee, Jeong Hoon Park, & Dong‐Jo Chang. (2020). Synthesis of imatinib, a tyrosine kinase inhibitor, labeled with carbon‐14. Journal of Labelled Compounds and Radiopharmaceuticals. 63(4). 174–182. 1 indexed citations
8.
Kang, Julie, et al.. (2020). Molecular design of fluorescent pH sensors based on reduced rhodol by structure-pKa relationship for imaging of lysosome. Dyes and Pigments. 184. 108785–108785. 24 indexed citations
9.
Lee, Jun Young, Dong‐Yeon Kim, Ayoung Pyo, et al.. (2018). Acetazolamide-based [18F]-PET tracer: In vivo validation of carbonic anhydrase IX as a sole target for imaging of CA-IX expressing hypoxic solid tumors. Bioorganic & Medicinal Chemistry Letters. 28(5). 915–921. 18 indexed citations
10.
Kang, Julie, Jun Young Lee, İsa Taş, et al.. (2018). Radiosynthesis, biological evaluation and preliminary microPET study of 18F-labeled 5-resorcinolic triazolone derivative based on ganetespib targeting HSP90. Bioorganic & Medicinal Chemistry Letters. 28(23-24). 3658–3664. 8 indexed citations
11.
Kim, Kyeojin, Su‐Jung Kim, Young Taek Han, et al.. (2015). Identification of small molecule inhibitors of the STAT3 signaling pathway: Insights into their structural features and mode of action. Bioorganic & Medicinal Chemistry Letters. 25(22). 5444–5448. 12 indexed citations
12.
Lee, Seungbeom, Hongchan An, Dong‐Jo Chang, et al.. (2015). Total synthesis of (−)-deguelin via an iterative pyran-ring formation strategy. Chemical Communications. 51(43). 9026–9029. 14 indexed citations
13.
Chang, Dong‐Jo, et al.. (2014). Discovery of structurally simplified analogs of colchicine as an immunosuppressant. Bioorganic & Medicinal Chemistry Letters. 24(14). 3121–3125. 1 indexed citations
14.
Jang, Jaebong, Jong‐Wha Jung, Jaehoon Sim, et al.. (2012). Asymmetric formal synthesis of schulzeines A and C. Organic & Biomolecular Chemistry. 10(27). 5202–5202. 13 indexed citations
15.
Chang, Dong‐Jo, et al.. (2012). Part II. Development of novel colchicine-derived immunosuppressants with improved pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 22(21). 6750–6755. 3 indexed citations
16.
Paek, Seung‐Mann, Nam‐Jung Kim, Dongyun Shin, et al.. (2010). A Concise Total Synthesis of (+)‐Tetrabenazine and (+)‐α‐Dihydrotetrabenazine. Chemistry - A European Journal. 16(15). 4623–4628. 34 indexed citations
17.
Kim, Nam‐Jung, Taesun Park, Hwayoung Yun, et al.. (2010). Concise and Enantioselective Total Synthesis of 15-Deoxy-Δ12,14-Prostaglandin J2. The Journal of Organic Chemistry. 75(21). 7458–7460. 25 indexed citations
18.
Li, Fu-Nan, Nam‐Jung Kim, Dong‐Jo Chang, et al.. (2009). Synthesis and structural optimization of multiple H-bonding region of diarylalkyl (thio)amides as novel TRPV1 antagonists. Bioorganic & Medicinal Chemistry. 17(24). 8149–8160. 5 indexed citations
19.
Chang, Dong‐Jo, et al.. (2009). Design, synthesis and identification of novel colchicine-derived immunosuppressant. Bioorganic & Medicinal Chemistry Letters. 19(15). 4416–4420. 21 indexed citations
20.
Paek, Seung‐Mann, Hwayoung Yun, Nam‐Jung Kim, et al.. (2008). Concise Syntheses of (+)-Macrosphelides A and B: Studies on the Macro-Ring Closure Strategy. The Journal of Organic Chemistry. 74(2). 554–561. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026